100 help plan
Shengxiang Biotechnology: The company's products have obtained the medical device registration certificate
Shengxiang Biotech announced that the company's product novel coronavirus (2019-NCOV) nucleic acid detection kit (fluorescent PCR method) recently received the "Medical Device Registration Certificate" issued by the State Food and Drug Administration.
Fenda Technology: Signed a strategic cooperation framework agreement with Feixi Robot
Fenda Technology announced that in order to further seize the development opportunities of the robot industry, the company and Shanghai Feixi Robot Technology Co., Ltd. recently signed the "Strategic Cooperation Framework Agreement". The two parties will make use of their differentiated advantages in the industrial chain to promote comprehensive strategic cooperation in manufacturing. Feixi Robot confirmed that Fenda Technology is its strategic cooperation base for product manufacturing, and the large-scale industrial manufacturing of relevant mature products (such as various intelligent robot arms, peripherals, application workstations, etc.) or parts identified by Feixi Robot will be given priority to be undertaken by Fenda Technology.
Pawa shares: plans to repurchase shares for 20 million yuan to 40 million yuan].
Pawa shares announced that the company intends to use its own funds to repurchase the company's shares in a centralized bidding transaction, which will be used to cancel and reduce the registered capital in accordance with the law. The total amount of repurchase funds shall not be less than 20 million yuan, not more than 40 million yuan, and the repurchase ** shall not exceed 3061 yuan shares.
CNGR Co., Ltd.: The subsidiary plans to increase capital and expand shares to introduce four institutions including ABC Investment
CNGR announced that Guangxi Zhongwei New Energy, a wholly-owned subsidiary of the company, intends to introduce ABC Investment, CCB Investment, Oriental Assets and Bank of China Assets through capital increase and share expansion, of which ABC Investment will increase its capital by 700 million yuan in cash, CCB Investment will increase its capital by 500 million yuan in cash, Oriental Assets will increase its capital by 500 million yuan in cash and BOC Assets will increase its capital by 500 million yuan in cash. After the completion of the capital increase, the company's shareholding in Guangxi Zhongwei New Energy decreased from 100% to 803220%, Guangxi Zhongwei New Energy is still the company's holding subsidiary.
All senior management personnel of Kaiying Network plan to increase their holdings by no less than RMB 8 million.